HAVN LIFE SCIENCES INC News

HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance

Biotech psychedelics company HAVN Life Sciences Inc. (OTC:HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean ("ABO"), previously announced on July 2

Benzinga Real-time NewsAug 20, 2022 04:10

HAVN Life Sciences announces 1-for-30 reverse stock split

HAVN Life Sciences (OTCPK:HAVLF) announced Friday the reverse stock split at 1-for-30 of its shares.  Stock will begin trading on a consolidated basis on August 3, ‎‎2022, with a new CUSIP number. As

Seeking AlphaJul 30, 2022 05:01

HAVN Life Announces a 30:1 Consolidation of its Common Shares

VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardize

GlobeNewswireJul 30, 2022 04:35

HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC:HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its the

Benzinga Real-time NewsJun 29, 2022 03:30

HAVN Life enters supply agreement with MPB Group

HAVN Life Sciences (OTCPK:HAVLF) enters into a supply partnership with a comprehensive outpatient mental health clinic, MPB Group. MPB Group is partnered with Healing Escapes Foundation retreats, a n

Seeking AlphaJun 28, 2022 19:39

HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022

VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigat

AccesswireApr 30, 2022 20:07

HAVN Life expands supply agreement with Mycotopia Therapies

HAVN Life Sciences (OTCPK:HAVLF) has expanded its supply partnership with Mycotopia Therapies, adding a second supply agreement that covers functional mushrooms, HAVN Life's recently launched natural

Seeking AlphaMar 22, 2022 21:14

HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market

HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, annou

Benzinga Real-time NewsFeb 11, 2022 11:06

Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base

Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc. The Deal Details Under the deal between HAVN Life, its newly i

Benzinga Real-time NewsDec 21, 2021 03:52

HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada

Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with international delivery - not an easy task. M

Benzinga Real-time NewsNov 24, 2021 03:26

Press Release: HAVN Life Announces Departure of Rick Brar as Director

HAVN Life Announces Departure of Rick Brar as Director Canada NewsWire VANCOUVER, BC, Oct. 25, 2021 VANCOUVER, BC, Oct. 25, 2021 /CNW/ - HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF

Dow Jones NewswiresOct 25, 2021 20:10

Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics

Last Week In Psychedelics:CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs   Octarine Bio and Clerkenwell Health Partner Up For Clinical Trials Mydecine To Launch Smoking Cessat

Benzinga Real-time NewsSep 14, 2021 01:37

HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies

The partnership will further industry growth for naturally derived psilocybinVANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" o

AccesswireAug 25, 2021 08:00

Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public

Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public

BenzingaMay 17, 2021 21:02